Influenza: Can we cope better with the unpredictable?

Human Vaccines and Immunotherapeutics

Volumn 12, Issue 3, 2016, Pages 699-708

  Dos Santos, Gaël ^a   Neumeier, Elisabeth ^b   Bekkat Berkani, Rafik ^a  

^a GSK   (Belgium)

^b GSK Vaccines   (Germany)

Author keywords

circulating strains; influenza; vaccine preventable diseases; vaccines and immunisation

Indexed keywords

INFLUENZA VACCINE; VIRUS ANTIGEN;

ANTIGENIC VARIATION; ARTICLE; DRUG EFFICACY; GEOGRAPHIC DISTRIBUTION; HUMAN; INFLUENZA; INFLUENZA A VIRUS; INFLUENZA A VIRUS (H1N1); INFLUENZA A VIRUS (H3N2); INFLUENZA B VIRUS; INFLUENZA VACCINATION; MICROBIOLOGICAL PARAMETERS; NORTHERN HEMISPHERE; SEASONAL INFLUENZA; SEASONAL VARIATION; SOUTHERN HEMISPHERE; STRAIN MISMATCH; VIRUS CHARACTERIZATION; VIRUS STRAIN; WORLD HEALTH ORGANIZATION; GENETICS; GLOBAL HEALTH; IMMUNOLOGY; INFLUENZA, HUMAN; ISOLATION AND PURIFICATION; ORTHOMYXOVIRIDAE; TREATMENT OUTCOME; VIROLOGY;

ANTIGENS, VIRAL; GLOBAL HEALTH; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; ORTHOMYXOVIRIDAE; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION;

EID: 84976484405     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.1080/21645515.2015.1086047     Document Type: Article

References (31)

1. World Health Organization (WHO). Influenza (Seasonal): http://www.who.int/mediacentre/factsheets/fs211/en/ Accessed October 13, 2014.
2. Vaccines against influenza WHO position paper – November 2012. Wkly Epidemiol Rec 2012; 87(47):461-76; PMID:23210147
3. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1999; 48(RR-4):1-28; PMID:10366138
4. World Health Organization (WHO). Global influenza surveillance and response system (GISRS): http://www.who.int/influenza/gisrs_laboratory/en/ Accessed October 13, 2014
5. World Health Organization (WHO). Influenza. WHO Recommendations Composition Influenza Virus Vaccines 2014: http://www.who.int/influenza/vaccines/virus/recommendations/en/ Accessed December 14, 2014
6. A.C.Tricco, A.Chit, C.Soobiah, D.Hallett, G.Meier, M.H.Chen, M.Tashkandi, C.T.Bauch, M.Loeb. Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysis. BMC Med 2013; 11:153; PMID:23800265; http://dx.doi.org/10.1186/1741-7015-11-153
7. CDC. Centers for disease control and prevention. Past Weekly Surveillance Rep 2015: http://www.cdc.gov/flu/weekly/pastreports.htm Accessed March 9, 2015
8. CDC Centers for Disease Control and Prevention. Weekly U.S. influenza surveillance report. 2015: http://www.cdc.gov/flu/weekly/ Accessed February 12, 2015
9. Public Health Agency of Canada. FluWatch. 2015: http://www.phac-aspc.gc.ca/fluwatch/14-15/w01_15/index-eng.php Accessed February 12, 2015
10. Centers for Disease Control and Prevention. Seasonal influenza vaccine effectiveness, 2005-2015, 2015: http://www.cdc.gov/flu/professionals/vaccination/effectiveness-studies.htm Accessed April 26, 2015
11. ECDC. European Centre for Disease Prevention and Control: http://www.ecdc.europa.eu/en/publications/surveillance_reports/Pages/index.aspx Accessed March 1, 2015
12. Estimates of deaths associated with seasonal influenza — United States, 1976–2007: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5933a1.htm Accessed March 25, 2015
13. I.M.Foppa, P.-Y.Cheng, S.B.Reynolds, D.K.Shay, C.Carias, J.S.Bresee, I.K.Kim, M.Gambhir, A.M.Fry. Deaths averted by influenza vaccination in the U.S. during the seasons 2005/06 through 2013/14. Vaccine 2015; 33(26):3003-9; PMID:25812842; http://dx.doi.org/10.1016/j.vaccine.2015.02.042
14. P.Mangtani, P.Cumberland, C.R.Hodgson, J.A.Roberts, F.T.Cutts, A.J.Hall. A cohort study of the effectiveness of influenza vaccine in older people, performed using the United Kingdom general practice research database. J Infect Dis 2004; 190(1):1-10; PMID:15195237; http://dx.doi.org/10.1086/421274
15. C.R.Simpson, N.Lone, K.Kavanagh, L.D.Ritchie, C.Robertson, A.Sheikh, J.McMenamin. Seasonal Influenza Vaccine Effectiveness (SIVE): an observational retrospective cohort study – exploitation of a unique community-based national-linked database to determine the effectiveness of the seasonal trivalent influenza vaccine [Internet]. Southampton (UK): NIHR J Lib 2013: http://www.ncbi.nlm.nih.gov/books/NBK263263/ Accessed April 27, 2015
16. Centers for Disease Control and prevention. CDC health advisory regarding the potential for circulation of drifted influenza a (H3N2) viruses. 2014: http://emergency.cdc.gov/HAN/han00374.asp Accessed April 26, 2015
17. E.Broberg, R.Snacken, C.Adlhoch, J.Beaute, M.Galinska, D.Pereyaslov, C.Brown, P.Penttinen, WHO European Region and the European Influenza Surveillance Network. Start of the 2014/15 influenza season in Europe: drifted influenza A(H3N2) viruses circulate as dominant subtype. Euro Surveill 2015; 20(4):pii21023; PMID:25655052
18. Centers for Disease Control and Prevention. CDC: flu activity expands; severity similar to past H3N2 seasons. 2015: http://www.cdc.gov/flu/news/flu-activity-expands.htm Accessed February 12, 2015
19. S.McNeil, M.Andrew, F.Haguinet, T.Hatchette, M.El Sherif, J.LeBlanc, A.Ambrose, A.McGeer, J.E.McElhaney, M.Loeb, et al. Interim estimates of 2014/15 influenza vaccine effectiveness in preventing laboratory-confirmed influenza-related hospitalisation from the Serious Outcomes Surveillance Network of the Canadian Immunization Research Network, January 2015. Euro Surveill 2015; 20(5):pii21024; PMID:25677052
20. B.Flannery, J.Clippard, R.K.Zimmerman, M.P.Nowalk, M.L.Jackson, L.A.Jackson, A.S.Monto, J.G.Petrie, H.Q.McLean, E.A.Belongia, et al. Early estimates of seasonal influenza vaccine effectiveness - United States, January 2015. MMWR Morb Mortal Wkly Rep 2015; 64(1):10-5; PMID:25590680
21. R.G.Pebody, F.Warburton, J.Ellis, N.Andrews, C.Thompson, B.von Wissmann, H.Green, S.Cottrell, J.Johnston, S.de Lusignan, et al. Low effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 mid–season results. Euro Surveill 2015; 20(5):pii=21025; PMID:25677050
22. D.Skowronski, C.Chambers, S.Sabaiduc, De G.Serres, J.Dickinson, A.Winter, S.Drews, K.Fonseca, H.Charest, J.Gubbay, et al. Interim estimates of 2014/15 vaccine effectiveness against influenza A(H3N2) from Canada s Sentinel Physician Surveillance Network, January 2015. Euro Surveill 2015; 20(4)
23. World Health Organization. Seasonal influenza vaccines 2014–2015 provide protection against circulating flu viruses. 2014; http://www.euro.who.int/en/health-topics/communicable-diseases/influenza/news/news/2014/12/seasonal-influenza-vaccines-20142015-provide-protection-against-circulating-flu-viruses. Accessed February 12, 2015
24. Rapid Risk Assessment. Circulation of drifted influenza A(H3N2) viruses in the EU/EEA. 22 December 2014 ECDC. Euro Centre Dis Prevent Control: http://ecdc.europa.eu/en/publications/Publications/RRA-InfluenzaA-H3N2-Dec-2014.pdf Accessed February 12, 2015
25. A.M.Fry, I.K.Kim, C.Reed, M.Thompson, S.S.Chaves, L.Finelli, J.Bresee. Modeling the effect of different vaccine effectiveness estimates on the number of vaccine-prevented influenza-associated hospitalizations in older adults. Clin Infect Dis 2014; 59(3):406-9; PMID:24803379; http://dx.doi.org/10.1093/cid/ciu328
26. 3rd WHO Informal Consultation for Improving Influenza Vaccine Virus Selection. 2014; http://www.who.int/influenza/vaccines/virus/3rdmtg_improve_vaccine_virus_selection/en/ Accessed February 12, 2015
27. H.S.Izurieta, N.Thadani, D.K.Shay, Y.Lu, A.Maurer, I.M.Foppa, R.Franks, D.Pratt, R.A.Forshee, T.MaCurdy, et al. Comparative effectiveness of high-dose versus standard-dose influenza vaccines in US residents aged 65 years and older from 2012 to 2013 using Medicare data: a retrospective cohort analysis. Lancet Infect Dis 2015; 15(3):293-300; PMID:25672568; http://dx.doi.org/10.1016/S1473-3099(14)71087-4
28. C.A.DiazGranados, A.J.Dunning, M.Kimmel, D.Kirby, J.Treanor, A.Collins, R.Pollak, J.Christoff, J.Earl, V.Landolfi, et al. Efficacy of high-dose versus standard-dose influenza vaccine in older adults. N Engl J Med 2014; 371(7):635-45; PMID:25119609; http://dx.doi.org/10.1056/NEJMoa1315727
29. C.Reed, M.I.Meltzer, L.Finelli, A.Fiore. Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine. Vaccine 2012; 30(11):1993-8; PMID:22226861; http://dx.doi.org/10.1016/j.vaccine.2011.12.098
30. F.Krammer, P.Palese. Advances in the development of influenza virus vaccines. Nat Rev Drug Discov 2015; 14(3):167-82; PMID:25722244; http://dx.doi.org/10.1038/nrd4529
31. H.Zhang, L.Wang, R.W.Compans, B.-Z.Wang. Universal influenza vaccines, a dream to be realized soon. Viruses 2014; 6(5):1974-91; PMID:24784572; http://dx.doi.org/10.3390/v6051974